Doppler ultrasound can help determine if a baby is allergic to cow’s milk based on the thickness and blood-vessel density in the bowel wall, a team of Brazilian researchers has found.
Doppler ultrasound can help determine if a baby is allergic to cow’s milk based on the thickness and blood-vessel density in the bowel wall, a team of Brazilian researchers has found.
In a study published in the June edition of the American Journal of Roentgenology (AJR 2011; Vol.196:6; W817-W822), researchers considered grayscale and color Doppler sonograms of 34 infants ranging in age from newborn to six months. Half were suspected of being allergic to cow’s milk; the other half served as controls. A blinded investigator determined the percentage of vessel density and thickness of different parts of the bowel at the start of the study, after four weeks of feeding only amino acid-based formula, and after a cow’s milk challenge test lasting up to a week.
The researchers found stark differences in the percentage of blood-vessel density between the babies that actually had a milk allergy (28.1 percent mean vessel density) and those who did not (7.77 percent mean density). By establishing a vessel density cutoff point at 18.7 percent, lead author Matias Epifano, MD, and colleagues found they could differentiate infants with milk allergies with roughly 82 percent sensitivity and 94.1 percent specificity. They also found statistical differences in bowel-wall thickness between control patients and those allergic to milk.
An estimated 2 percent to 7.5 percent of infants worldwide have a milk allergy.
The study: http://www.ajronline.org/cgi/content/abstract/196/6/W817
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Clears Ultrasound AI Detection for Pleural Effusion and Consolidation
June 18th 2025The 14th FDA-cleared AI software embedded in the Exo Iris ultrasound device reportedly enables automated detection of key pulmonary findings that may facilitate detection of pneumonia and tuberculosis in seconds.